Laringite

House S A, Fisher E L. Hoarseness in adults. Am Fam Physician. 2017 Dec 1;96(11):720-8.Texto completo

Dworkin JP. Laryngitis: types, causes, and treatments. Otolaryngol Clin North Am. 2008 Apr;41(2):419-36. Resumo

Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg. 2018 Mar;158(1_suppl):S1-S42.Texto completo  Resumo

1. Zhukhovitskaya A, Verma SP. Identification and Management of Chronic Laryngitis. Otolaryngol Clin North Am. 2019 Aug;52(4):607-16.Texto completo  Resumo

2. House S A, Fisher E L. Hoarseness in adults. Am Fam Physician. 2017 Dec 1;96(11):720-8.Texto completo

3. Alcaide ML, Bisno AL. Pharyngitis and epiglottitis. Infect Dis Clin North Am. 2007 Jun;21(2):449-69, Resumo

4. Wood JM, Athanasiadis T, Allen J. Laryngitis. BMJ. 2014 Oct 9;349:g5827.Texto completo  Resumo

5. Stein DJ, Noordzij JP. Incidence of chronic laryngitis. Ann Otol Rhinol Laryngol. 2013 Dec;122(12):771-4.Texto completo  Resumo

6. Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of laryngitis, wheezing bronchitis and bronchiolitis in children. Acta Paediatr. 2016 Jan;105(1):44-9. Resumo

7. Frantz TD, Rasgon BM. Acute epiglottitis: changing epidemiologic patterns. Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 1):457-60. Resumo

8. World Health Organization. Global health observatory data repository​: diphtheria - reported cases by WHO region. Jul 2023 [internet publication].Texto completo

9. Khan A, Rebhan A, Seminara D, et al. Enduring Challenge of Latent Tuberculosis in Older Nursing Home Residents: A Brief Review. J Clin Med Res. 2019 Jun;11(6):385-90.Texto completo  Resumo

10. World Health Organization. Tuberculosis. Oct 2024 [internet publication].Texto completo

11. Getahun H, Gunneberg C, Granich R, et al. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010 May 15;50(Suppl 3):S201-7.Texto completo  Resumo

12. Tulunay OE. Laryngitis - diagnosis and management. Otolaryngol Clin North Am. 2008 Apr;41(2):437-51. Resumo

13. Tristram D. Laryngitis, Tracheitis, Epiglottitis, and Bronchiolitis: Sore Throat, Change in Voice, Feverora Wheezing Infant in Respiratory Distress. Introduction to Clinical Infectious Diseases. 2018 Oct 15:75–85.Texto completo

14. Dworkin JP. Laryngitis: types, causes, and treatments. Otolaryngol Clin North Am. 2008 Apr;41(2):419-36. Resumo

15. Campagnolo AM, Priston J, Thoen RH, et al. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol. 2014 Apr;18(2):184-91.Texto completo  Resumo

16. Titze IR, Svec JG, Popolo PS. Vocal dose measures: quantifying accumulated vibration exposure in vocal fold tissues. J Speech Lang Hear Res. 2003 Aug;46(4):919-32.Texto completo  Resumo

17. Ingle JW, Helou LB, Li NY, et al. Role of steroids in acute phonotrauma: a basic science investigation. Laryngoscope. 2014 Apr;124(4):921-7. Resumo

18. Ben Gamra O, Mbarek C, Charfi S, et al. Chronic laryngitis in adults [in French]. Tunis Med. 2007 Aug;85(8):641-3. Resumo

19. Walls R, Murphy M. Manual of emergency airway management. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.

20. Sharma NC, Efstratiou A, Mokrousov I, et al. Diphtheria. Nat Rev Dis Primers. 2019 Dec 5;5(1):81.Texto completo  Resumo

21. Kirti YK. Reflux Finding Score (RFS) a Quantitative Guide for Diagnosis and Treatment of Laryngopharyngeal Reflux. Indian J Otolaryngol Head Neck Surg. 2018 Sep;70(3):362-5.Texto completo  Resumo

22. Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg. 2018 Mar;158(1_suppl):S1-S42.Texto completo  Resumo

23. Shohet JA, Courey MS, Scott MA, et al. Value of videostroboscopic parameters in differentiating true vocal fold cysts from polyps. Laryngoscope. 1996 Jan;106(1 Pt 1):19-26. Resumo

24. The National Centre for Infectious Diseases. Diphtheria. May 2021 [internet publication].Texto completo

25. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021 Dec 9;12(12):CD000023.Texto completo  Resumo

26. Reveiz L, Cardona AF. Antibiotics for acute laryngitis in adults. Cochrane Database Syst Rev. 2015;(5):CD004783.Texto completo  Resumo

27. Centers for Disease Control and Prevention. Clinical guidance for diphtheria. Feb 2024 [internet publication].Texto completo

28. Rafii B, Sridharan S, Taliercio S, et al. Glucocorticoids in laryngology: a review. Laryngoscope. 2014 Jul;124(7):1668-73. Resumo

29. Souza AM, Duprat Ade C, Costa RC, et al. Use of inhaled versus oral steroids for acute dysphonia. Braz J Otorhinolaryngol. 2013 Mar-Apr;79(2):196-202.Texto completo  Resumo

30. DelGaudio JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):677-81.Texto completo  Resumo

31. Klein AM, Johns MM 3rd. Vocal emergencies. Otolaryngol Clin North Am. 2007 Oct;40(5):1063-80, Resumo

32. de Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med. 2012 Jan 1;185(1):12-23.Texto completo  Resumo

33. Kuriyama A, Umakoshi N, Sun R. Prophylactic corticosteroids for prevention of postextubation stridor and reintubation in adults: a systematic review and meta-analysis. Chest. 2017 May;151(5):1002-10. Resumo

34. Haben CM. Voice rest and phonotrauma in singers. Med Probl Perform Art. 2012 Sep;27(3):165-8. Resumo

35. Garrett CG, Ossoff RH. Hoarseness. Med Clin North Am. 1999 Jan;83(1):115-23, Resumo

36. Centers for Disease Control and Prevention. CDC Yellow Book 2024: travel-associated infections and diseases. May 2023 [internet publication].Texto completo

37. UK Health Security Agency. Diphtheria: public health control and management in England. Nov 2023 [internet publication].Texto completo

38. Nunes FP, Bishop T, Prasad ML, et al. Laryngeal candidiasis mimicking malignancy. Laryngoscope. 2008 Nov;118(11):1957-9.Texto completo  Resumo

39. Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication].Texto completo